This comprehensive validation process culminated in the identification of two genes, DHX36 and GPR68, which demonstrated a direct causal relationship with CHD and were thus defined as biomarkers (Figure 5A–H) (Supplementry Tables S1–S3). Here, GPR68 is linked to coronary artery disorder.